Suppression of bone marrow-derived microglia in the amygdale improves anxiety-like behavior induced by chronic partial sciatic nerve ligation in mice

Pain

Volumn 155, Issue 9, 2014, Pages 1762-1772

  Sawada, Atsushi ^a   Niiyama, Yukitoshi ^a   Ataka, Koji ^a   Nagaishi, Kanna ^a   Yamakage, Michiaki ^a   Fujimiya, Mineko ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amygdala; Anxiety; Bone marrow derived microglia; Neuropathic pain

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2 ANTAGONIST; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RS 102895; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANXIETY DISORDER; ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CHRONIC PAIN; CONTROLLED STUDY; GENE EXPRESSION; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MAZE TEST; MECHANICAL STIMULATION; MICROGLIA; MOUSE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PARTIAL SCIATIC NERVE LIGATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SPINAL CORD DORSAL HORN; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; BONE MARROW; COMPLICATION; ETIOLOGY; INJURIES; METABOLISM; NERVE CELL; NEURALGIA; PHYSIOLOGY; SCIATIC NERVE; TRANSGENIC MOUSE;

AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BONE MARROW; CHEMOKINE CCL2; MALE; MICE; MICE, TRANSGENIC; MICROGLIA; NEURALGIA; NEURONS; SCIATIC NERVE;

EID: 84926407131     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2014.05.031     Document Type: Article

References (43)

1. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, Maclntyre DE, Forrest MJ. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A 2003;100:7947-52.
2. Amano T, Unal CT, Paré D. Synaptic correlates of fear extinction in the amygdala. Nat Neurosci 2010;13:489-94.
3. Ambrosini E, Aloisi F. Chemokines and glial cells: a complex network in the central nervous system. Neurochem Res 2004;29:1017-38.
4. Arnold LM, Leon T, Whalen E, Barrett J. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgis. Psychomatics 2010;51:489-97.
5. Ataka K, Asakawa A, Nagaishi K, Kaimoto K, Sawada A, Hayakawa Y, Tatezawa R, Inui A, Fujimiya M. Bone marrow-derived microglia infiltrate into the paraventricular nucleus of chronic psychological stress-loaded mice. PLoS One 2013;8:e81744. http://dx.doi.org/10.1371/journal.pone.0081744.
6. Avrabos C, Sotnikov SV, Dine J, Markt PO, Holsboer F, Landgraf R, Eder M. Realtime imaging of amygdalar network dynamics in vitro reveals a neurophysiological link to behavior in a mouse model of extremes in trait anxiety. J Neurosci 2013;33:16262-7.
7. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163:2433-45.
8. Baron R. Mechanisms of disease: neuropathic pain-a clinical perspective. Nat Clin Pract Neurol 2006;2:95-106.
9. Brevet M, Kojima H, Asakawa A, Atsushi K, Ushikai M, Ataka K, Inui A, Kimura H, Sevestre H, Fujimiya M. Chronic foot-shock stress potentiates the influx of bone marrow-derived microglia into hippocampus. J Neurosci Res 2010;88:1890-7.
10. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63.
11. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005;438:1017-21.
12. Dersh J, Polatin PB, Gatchel RJ. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med 2002;64:773-86.
13. Diaz MR, Chappell AM, Christian DT, Anderson NJ, McCool BA. Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral/basolateral amygdala. Neuropsychopharmacology 2011;36:1090-103.
14. Guindon J, Hohmann AG. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 2008;153:319-34.
15. Inoue K, Tsuda M. Microglia and neuropathic pain. Glia 2009;57:1469-79.
16. Iversen L. Cannabis and the brain. Brain 2003;126:1252-70.
17. Malmberg AB, Basbaum AI. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. PAIN 1998;76:215-22.
18. Maren S. Synaptic mechanisms of associative memory in the amygdala. Neuron 2005;47:783-6.
19. Matsuzawa-Yanagida K, Narita M, Nakajima M, Kuzumaki N, Niikura K, Nozaki H, Takagi T, Tamai E, Hareyama N, Terada M, Yamazaki M, Suzuki T. Usefulness of antidepressants for improving the neuropathic pain-like state and paininduced anxiety through actions at different brain sites. Neuropsychopharmacology 2008;33:1952-65.
20. McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. PAIN 2003;106:127-33.
21. Nadal R, Escorihuela RM, Armario A. In: Anderson MJ, editor. The elevated plus-maze test of anxiety: methodological considerations. A sampling of methodologies of the investigation of animal learning behavior and cognition. New York: Nova Science Publishers; 2006. p. 25-37.
22. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 2006;31:739-50.
23. Norman GJ, Karelina K, Zhang N, Walton JC, Morris JS, Devries AC. Stress and IL-1b contribute to the development of depressive-like behavior following peripheral nerve injury. Mol Psychiatry 2010;15:404-14.
24. Pare D, Duvarci S. Amygdala microcircuits mediating fear expression and extinction. Curr Opin Neurobiol 2012;22:717-23.
25. Phelps EA, LeDoux JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005;48:175-87.
26. Rebenko-Moll NM, Liu L, Cardona A, Ransohoff RM. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr Opin Immunol 2006;18:683-9.
27. Rhudy JL, Meagher MW. Negative affect: effects on an evaluative measure of human pain. PAIN 2003;104:617-26.
28. Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, Musella A, Barbieri F, Bari M, Bernardi G, Maccarrone M, Usiello A, Centonze D. Interleukin-1b causes anxiety by interacting with the endocannabinoid system. J Neurosci 2012;32:13896-905.
29. Saijo K, Glass CK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 2011;11:775-87.
30. Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. PAIN 1990;43:205-18.
31. Semple BD, Bye N, Rancan M, Ziebell JM, Morganti-Kossmann MC. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/-mice. J Cereb Blood Flow Metab 2010;30:769-82.
32. Sotres-Bayon F, Bush DE, LeDoux JE. Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala. Neuropsychopharmacology 2007;32:1929-40.
33. Trang T, Beggs S, Wan X, Salter MW. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci 2009;29:3518-28.
34. Tsuda M, Masuda T, Tozaki-Saitoh H, Inoue K. Microglial regulation of neuropathic pain. J Pharmacol Sci 2013;121:89-94.
35. Tye KM, Prakash R, Kim SY, Fenno LE, Grosenick L, Zarabi H, Thompson KR, Gradinaru V, Ramakrishnan C, Deisseroth K. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011;471:358-62.
36. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M. Interleukin-1 beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003;23: 8692-700.
37. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. PAIN 2000;85:317-32.
38. Watabe AM, Ochiai T, Nagase M, Takahashi Y, Sato M, Kato F. Synaptic potentiation in the nociceptive amygdala following fear learning in mice. Mol Brain 2013;6:11. http://dx.doi.org/10.1186/1756-6606-6-11.
39. White FA, Feldman P, Miller RJ. Chemokine signaling and the management of neuropathic pain. Mol Interv 2009;9:188-95.
40. Wohleb ES, Powell ND, Godbout JP, Sheridan JF. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J Neurosci 2013;33:13820-33.
41. Xie J, Bi Q, Shang W, Yan M, Yang Y, Miso D, Zhang H. Positive and negative relationship between anxiety and depression of patients in pain a bifactor model analysis. PLoS One 2012;7:e47577. http://dx.doi.org/10.1371/ journal.pone.0047577.
42. Zald DH. The human amygdala and the emotional evaluation of sensory stimuli. Brain Res Brain Res Rev 2003;41:88-123.
43. Zhang J, Shi XQ, Echeverry S, Mogil JS, Koninck Y, Rivest S. Expression of CCR2 in both resident and bone marrow derived microglia plays a critical role in neuropathic pain. J Neurosci 2007;27:12396-406.